BioAdvance News

QR Pharma Raises $800,000 of Series A Preferred Stock

By WebmasterOctober 27, 2016November 1st, 2024No Comments

QR Pharma Raises $800,000 of Series A Preferred Stock

Previous PostGenPro publishes EpiMarker feasibility study revealing distinct epigenetic signature of Parkinson's Disease in blood
Next PostRelmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms